Most healthy men produce sufficient testosterone as they age. Yet online ads and telehealth sites are promoting testosterone drugs with flawed promises of boosting libido and busting stomach fat.
Savings estimated by the Congressional Budget Office from allowing the federal government to negotiate Medicare drug prices are based on a 10-year cumulative projection.
With U.S. syphilis rates climbing to the worst level in seven decades, public health experts and the federal Indian Health Service are scrambling to detect and treat the disease in Native American communities, where babies are infected at a higher rate than in any other demographic.
Republican Gov. Brian Kemp’s Georgia Pathways to Coverage program has seen anemic enrollment while chalking up millions in start-up costs — largely in technology and consulting fees. Critics say the money’s being wasted on a costly and ineffective alternative to Obamacare’s Medicaid expansion.
The pain and trauma from repeated needle sticks leads some kids to hold on to needle phobia into adulthood. Research shows the biggest source of pain for children in the health care system is needles. But one doctor thinks he has a solution and is putting it into practice at two children’s hospitals in Northern California.
Some Americans mistakenly believe medication to prevent HIV transmission through sex is just for certain groups such as gay men, but anyone who’s at risk for contracting HIV through sex could benefit.
Peer leaders can help ease the shortage of mental health providers and build trust through shared experiences, state health officials say. In 2022, California started allowing counties to use Medicaid dollars to pay them for their work.
As money flows to abortion rights initiatives in states, some donors focus on where anger over the “Dobbs” ruling could propel voter turnout and spur Democratic victories up and down the ballot, including in key Senate races and the White House.
Four years since the covid pandemic emerged, health care workers want rules that protect them during outbreaks. They worry the CDC is repeating past mistakes as it develops a crucial set of guidelines for hospitals, nursing homes, prisons, and other facilities that provide health care.
Demand for help monitoring patients’ vital signs remotely has taken off since a Medicare change in 2019. Dozens of companies now push the service to help overburdened primary care doctors — and as a revenue stream. But some policy experts say its growth has outpaced oversight and evidence of effectiveness.
After California passed the first law in the nation to limit the disavowed term “excited delirium,” bills in other states are being introduced to help end use of the diagnosis. But momentum is being met with resistance from law enforcement and first responder groups, who cite free speech.
Drugmakers offer copay assistance programs to patients, but insurers are tapping into those funds, not counting the amounts toward patient deductibles. That leads to unexpected charges. But the practice is under growing scrutiny.
New federal funds aim to address an array of problems created by highway construction in minority neighborhoods. These are economic, social, and, perhaps above all, public health problems. In New Orleans’ Treme neighborhood, competing plans for how to deal with harm done by the Claiborne Expressway reveal the challenge of how to mitigate them meaningfully.
One of the most unfair aspects of medical insurance is this: Patients can change insurance only during end-of-year enrollment periods or at the time of “qualifying life events.” But insurers’ contracts with doctors, hospitals, and pharmaceutical companies can change abruptly at any time.
Health care wasn’t expected to be a major theme for this year’s elections. But as President Joe Biden and former President Donald Trump secured their respective party nominations this week, the future of both Medicare and the Affordable Care Act appears to be up for debate. Meanwhile, the cyberattack of the UnitedHealth Group subsidiary Change Healthcare continues to do damage to the companies’ finances with no quick end in sight. Margot Sanger-Katz of The New York Times, Anna Edney of Bloomberg News, and Joanne Kenen of Johns Hopkins University and Politico Magazine join KFF Health News’ Julie Rovner to discuss these issues and more. Also this week, Rovner interviews Kelly Henning of Bloomberg Philanthropies about a new, four-part documentary series on the history of public health, “The Invisible Shield.” Plus, for “extra credit” the panelists suggest health policy stories they read this week that they think you should read, too.
In the first of our series “The Injured,” a Kansas family remembers Valentine’s Day as the beginning of panic attacks, life-altering trauma, and waking to nightmares of gunfire. Thrown into the spotlight by the shootings, they wonder how they will recover.
A 25-year-old state Supreme Court ruling protects abortion rights in conservative Montana. That hasn’t stopped Republicans and anti-abortion advocates from trying to institute a ban.